|

Patient Blood Management in Patients Scheduled for Cardiac Surgery

RECRUITINGSponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Actively Recruiting
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Started2025-02-24
Est. completion2027-02-28
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06637137

Summary

The ICARUS 2 study has the general objective of collecting data in patients undergoing cardiac surgery; in our centre, in order to optimize and improve hemoglobin values, a team of haematologists, assisted by cardio anesthetists and cardiac surgeons, will evaluate the blood tests of patients scheduled for elective cardiac surgery in order to correct any states of hypoferritinemia (low iron in the blood) to promote recovery from blood losses related to cardiac surgery. This objective is strongly encouraged by the good use of blood programs currently in force at our foundation. In particular, the research presented here intends to demonstrate a reduction in the number of intra- and post-operative transfusions.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

\- all adult patients scheduled for elective cardiac surgery

Exclusion Criteria:

* pregnancy
* dyalisis
* patient's refusal

Conditions7

AnemiaAnemia, Iron-DeficiencyBlood Loss, SurgicalCardiac Surgical PatientsHeart DiseaseIron Deficiency Anemia (IDA)Iron Deficiency Anemia Treatment

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.